Board of Directors/Advisors

Professor Florian Solzbacher

Professor Solzbacher is Executive Director of the Utah Nanofabrication Laboratory, Co-Director of the Utah Nanotechnology Institute, President and Executive Chairman of Blackrock Microsystems and of Blackrock Neuromed and is a Professor in Electrical and Computer Engineering with adjunct appointments in Materials Science and Bioengineering at the University of Utah. His research focuses on harsh environment microsystems and materials, including implantable, wireless microsystems for biomedical and healthcare applications, and on high temperature and harsh environment compatible micro sensors. Prof. Solzbacher received his M.Sc. EE from the Technical University Berlin in 1997 and his Ph.D. from the Technical University Ilmenau in 2003. He is co-founder of several companies such as Blackrock Microsystems, Blackrock Neuromed, and First Sensor Technology. He was a board member and Chairman of the German Association for Sensor Technology AMA and of Sensor + Test trade show and conference from 2001 until 2009, and serves on a number of company and public private partnership advisory boards and international conference steering committees. He is author of over 190 journal and conference publications, 5 book chapters and 16 pending patents.

Marcus Gerhardt

Marcus is an entrepreneur and investment advisor focused on innovation technologies and alternative investment markets. In 1999, Marcus helped set up his first start-up, Mondus, a pioneering ecommerce platform. As Managing Director UK, he oversaw the growth of the company to 145 employees. He coordinated several funding rounds, raising in excess of $170 million, providing shareholders with a 10-fold exit through a trade sale to Seat Pagine Gialle. Subsequently, Marcus co-founded BBI which advises technology companies on funding, commercialization and growth strategies. He holds various board and advisory positions at companies such as ComoneaPro. Marcus has an MPhil from Oxford University.

Andy Gotshalk, CEO

Andy is a medical device executive with over 15 years experience. Prior to the spin-out from Blackrock Microsystems, Andy was the CEO of Blackrock Microsystems and he successfully commercialized research products in the neurophysiology sector increasing revenue from $700k to +$10 million in less than four years. Prior to Blackrock, Andy was responsible for sales and operations for the US Surgical Division of Haemonetics Corporation. Andy has a Bachelor of Science in Mechanical Engineering (with a focus in Bioengineering) from the Georgia Institute of Technology. In his spare time, he enjoys competitive sports, good local food and exploring the outdoors with his wife and two children.

David J. McNally

David is a successful serial entrepreneur and currently the CEO and President of Domain Surgical. He co-founded ZEVEX International in 1986, which became a NASDAQ-traded medical device company, and served as its Chief Executive Officer from 2000 to 2007. He led the company to earn medical device industry innovation awards and to be recognized as a technology leader in surgical instruments, medical sensors and fluid delivery systems. As CEO, he negotiated the $84 million sale of the company to strategic acquirer Moog in 2007. He is also the founding manager of NEXsprouT LLC, the technology commercialization company that seed funded Domain Surgical in 2009. Prior to ZEVEX, Mr. McNally held various positions in marketing and sales management with EDO Corporation and Physical Acoustics Corporation. He began his career as an advanced methods development engineer with Hercules Incorporated. Mr. McNally earned a Bachelor of Science degree in Mechanical Engineering from Lafayette College in 1983, with an emphasis in computers and instrumentation, and an Executive Master of Business Administration degree from the University of Utah in 1992. He is an inventor on 14 issued patents, with 16 additional patents pending.

Jeffrey B. Kindler

Jeff Kindler is an advisor to the Blackrock NeuroMed Board of Directors and a Venture Partner at Lux Capital, a leading venture capital firm. He also serves on the boards of Paragon Pharmaceuticals, AgaMatrix, Intrexon, Sheridan Healthcare, Tufts University, The National Center on Addiction and Substance Abuse at Columbia University, and the Manhattan Theatre Club. He is a member of President Obama’s Management Advisory Board and a director at Starboard Capital Partners, a Connecticut-based private equity firm.

Kindler formerly held positions as the Chairman and Chief Executive Officer of Pfizer, Vice President of Litigation and Legal Policy at General Electric Company, and Executive Vice President and General Counsel of McDonald’s Corporation. And he previously served as Chairman of PhRMA (Pharmaceutical Researchers and Manufacturers of America) and of the U.S.-Japan Business Council and as a member of the President’s Export Council, the Shanghai Mayor’s Business Advisory Council, the Business Council, and the Business Roundtable. Kindler holds a BA from Tufts University and a JD from Harvard.